Purple Biotech Ltd.-ADRPPBT
13F holders, Q2 2025 (June 30)12holders +4
3new positions
0sold out
$2.34avg. 13F price*
At the end of Q2 2025, 12 institutions reported holding Purple Biotech Ltd.-ADR (PPBT) in their 13F filings, up 4 from Q1 2025. 3 opened new positions and 0 sold out. The largest holders were UBS Group AG ($54K), Kingswood Wealth Advisors, LLC ($39K) and BNP Paribas Financial Markets ($15K).
- Company
- Purple Biotech Ltd.-ADR
- CUSIP
- 74638P208
- Latest filing quarter
- Q4 2025
History
Number of 13F holders
Total Exit/New Position Q1 2025 → Q2 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 3 | $12K |
| Exits | 0 | $0 |
All 13F filers, Q1 2025 → Q2 2025: 6,432 shares bought, net +6,432 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 12 holders
| UBS Group AG | 0.00% | Add +0.5% | 23,144 | $54K |
| Kingswood Wealth Advisors, LLC | 0.00% | No change | 16,797 | $39K |
| BNP Paribas Financial Markets | 0.00% | Add +16.7% | 6,275 | $15K |
| Morgan Stanley | 0.00% | Add +2.2% | 4,566 | $11K |
| GAMMA Investing LLC | 0.00% | New | 4,430 | $10K |
| Rhumbline Advisers | 0.00% | Add +34.2% | 1,080 | $3K |
| Raymond James Financial Inc. | 0.00% | New | 555 | $1K |
| Northwestern Mutual Wealth Management Co. | 0.00% | No change | 85 | $199 |
| SBI Securities Co., Ltd. | 0.00% | No change | 20 | $47 |
| Global Retirement Partners, LLC | 0.00% | — | 16 | $38 |
| Royal Bank of Canada | 0.00% | No change | 107 | $0 |
| Simplex Trading, LLC | 0.00% | New | 53 | $0 |
"% of holder's portfolio" is PPBT's weight in each manager's 13F, not the share of Purple Biotech Ltd.-ADR the manager owns.